Terms: = Lung cancer AND CCND3, P30281, 896, ENSG00000112576 AND Clinical Outcome
3 results:
1. Budget impact analysis of comprehensive genomic profiling for untreated advanced or recurrent solid cancers in Japan.
Tang W; Hanada K; Motoo Y; Sakamaki H; Oda T; Furuta K; Abutani H; Ito S; Tsutani K
J Med Econ; 2023; 26(1):614-626. PubMed ID: 37073487
[TBL] [Abstract] [Full Text] [Related]
2. [Real-world study on the efficacy and prognostic predictive biomarker of patients with metastatic non-small cell lung cancer treated with programmed death-1/programmed death ligand 1 inhibitors].
Zhu WJ; Zhu HH; Liu YT; Lin L; Xing PY; Hao XZ; Cong MH; Wang HY; Wang Y; Li JL; Feng Y; Hu XS
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):416-424. PubMed ID: 35615798
[No Abstract] [Full Text] [Related]
3. Video-assisted thoracoscopic surgery lobectomy might be a feasible alternative for surgically resectable pathological N2 non-small cell lung cancer patients.
Zhao J; Li W; Wang M; Liu L; Fu X; Li Y; Xu L; Liu Y; Zhao H; Hu J; Liu D; Shen J; Yang H; Li X
Thorac Cancer; 2021 Jan; 12(1):21-29. PubMed ID: 33205914
[TBL] [Abstract] [Full Text] [Related]
